AGP Executive Report
Last update: an hour agoHepatitis B: The FDA approved GSK’s Hibsago, a six-month add-on treatment for some adults with chronic hepatitis B. In trials, 19% achieved a functional cure, compared with none on placebo. Inmate Health Care: The Supreme Court rejected the administration’s bid to restrict gender-affirming treatment in federal prisons, leaving a lower-court block in place as the case continues. Rural Medication Access: A Minnesota startup and the University of Minnesota are testing a home pill dispenser that sends reminders and connects users with pharmacists, aiming to help older adults in communities with few pharmacies. Measles: U.S. cases have topped 4,400, while Pennsylvania officials warn of congenital measles after pregnant women contracted the disease. Medicaid Oversight: More than 100 adult daycare providers were targeted in a fraud investigation, as federal officials step up scrutiny of health-program spending.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
